These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 29463213)
1. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213 [TBL] [Abstract][Full Text] [Related]
2. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919 [TBL] [Abstract][Full Text] [Related]
3. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer. Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966 [TBL] [Abstract][Full Text] [Related]
4. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma. Liu Z; Ye Q; Wu L; Gao F; Xie H; Zhou L; Zheng S; Xu X Mol Carcinog; 2018 Nov; 57(11):1435-1444. PubMed ID: 29873415 [TBL] [Abstract][Full Text] [Related]
5. The impact of MCM6 on hepatocellular carcinoma in a Southern Chinese Zhuang population. Jia W; Xie L; Wang X; Zhang Q; Wei B; Li H; Qin S; Chen S; Liu J; Tan Y; Zheng S; Liang X; Yang X Biomed Pharmacother; 2020 Jul; 127():110171. PubMed ID: 32403044 [TBL] [Abstract][Full Text] [Related]
6. A Direct Interaction Between P53-Binding Protein 1 and Minichromosome Maintenance Complex in Hepg2 Cells. Chen Y; Weng C; Zhang H; Sun J; Yuan Y Cell Physiol Biochem; 2018; 47(6):2350-2359. PubMed ID: 29990989 [TBL] [Abstract][Full Text] [Related]
7. Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma. Cao T; Yi SJ; Wang LX; Zhao JX; Xiao J; Xie N; Zeng Z; Han Q; Tang HO; Li YK; Zou J; Wu Q Biomed Res Int; 2020; 2020():3574261. PubMed ID: 32964028 [TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein family member 6 mediates hepatocellular carcinoma progression by recruiting UBE3A to induce P53 ubiquitination. Zhang X; Bian S; Ni Y; Zhou L; Yang C; Zhang C; Sun X; Xu N; Xu S; Wang Y; Gu S; Zheng W Int J Biol Macromol; 2023 Sep; 248():125854. PubMed ID: 37460074 [TBL] [Abstract][Full Text] [Related]
9. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma. Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251 [TBL] [Abstract][Full Text] [Related]
10. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L Front Oncol; 2022; 12():1004324. PubMed ID: 36465369 [TBL] [Abstract][Full Text] [Related]
11. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
12. Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments. Lei Y; Wang S; Liu J; Yan W; Han P; Tian D Life Sci; 2021 May; 272():119227. PubMed ID: 33607151 [TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs. Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer. Wu B; Xi S BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366 [TBL] [Abstract][Full Text] [Related]
15. Hou L; Zeng X; Li X; Zhao C; Zou J; Li Y; Liu G Comput Math Methods Med; 2022; 2022():3116303. PubMed ID: 35720029 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
17. Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas. Hua C; Zhao G; Li Y; Bie L BMC Cancer; 2014 Jul; 14():526. PubMed ID: 25046975 [TBL] [Abstract][Full Text] [Related]
18. Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma. Liao X; Liu X; Yang C; Wang X; Yu T; Han C; Huang K; Zhu G; Su H; Qin W; Huang R; Yu L; Deng J; Zeng X; Ye X; Peng T J Cancer; 2018; 9(13):2357-2373. PubMed ID: 30026832 [No Abstract] [Full Text] [Related]
19. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells. Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]